Document is current

Article History

Accepted: 4 May 2025

First Online: 30 May 2025

Declarations

:

: Optum Life Sciences was contracted by Daiichi Sankyo, Inc. to conduct this analysis. The analysis was funded by Daichi Sankyo, Inc.

: Nicole M. Engel-Nitz is an employee of Optum Life Sciences and a shareholder in UnitedHealth Group. Amy Anderson and Summer Tran were employees of Optum Life Sciences at the time the analysis was conducted, and Amy Anderson is a shareholder in UnitedHealth Group. Kevin Wang is an employee of Daiichi Sankyo and Winghan Jacqueline Kwong was an employee of Daiichi Sankyo at the time this analysis was conducted.

: Institutional review board approval or a waiver of approval was not required for this study because the study data were secondary and de-identified in accordance with the United States Department of Health and Human Services Privacy Rule’s requirements for de-identification codified at 45 C.F.R. § 164.514(b).

: Not applicable.

: Not applicable.

: The data contained in the database used for the study contain proprietary elements owned by Optum and, therefore, cannot be broadly disclosed or made publicly available at this time. The disclosure of these data to third parties assumes certain data security and privacy protocols are in place and that the third party has executed a standard license agreement, which includes restrictive covenants governing the use of the data.

: Not applicable.

: All named authors meet the International Committee of Medical Journal Editors criteria for authorship for this article, take responsibility for the integrity of the work as a whole, contributed to the writing and reviewing of the manuscript, and have given final approval of the version to be published. NMEN, WJK, ST, and KW were involved in the conception and design of the study and data interpretation. NMEN and AA were involved in the acquisition of data. NMEN, ST, and AA were involved in the data analysis. All authors read and approved the final version.